Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

January 26, 2017

Primary Completion Date

April 12, 2019

Study Completion Date

April 12, 2019

Conditions
Non-small Cell Lung Cancer (NSCLC)Lung Metastasis
Interventions
DRUG

Porfimer sodium

After injection of porfimer sodium (Photofrin®), a flexible bronchoscopy with navigation guidance will be performed to confirm the location and the size of the lesion with the use of radial probe endobronchial ultrasonography (REBUS). A light dose of 200 J/cm of diffuser length will be delivered.

DEVICE

Fiber optic

A fiber optic diffuser length matching the tumor length will be placed in the lesion under fluoroscopy guidance.

Trial Locations (7)

30265

Southeastern Regional Medical Center, Atlanta

32611

University of Florida, Gainesville

53715

University of Wisconsin-Madison, Madison

60007

Alexian Brothers Hospital Network, Elk Grove Village

74133

Southwestern Regional Medical Center, Tulsa

99204

Providence Medical Research Center, Spokane

M5G2C4

Toronto General Hospital, Toronto

Sponsors
All Listed Sponsors
lead

Concordia Laboratories Inc.

INDUSTRY